Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treprostinil Inhalation Powder (TrIP) in healthy volunteers
NCT03464864Phase 1Completed
- Sponsor
- MannKind
- Start
- Mar 2018
- Primary completion
- Jun 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of treprostinil in pulmonary arterial hypertension (PAH), sponsored by MannKind. Started Mar 2018; status: completed.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03464864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03464864.